AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano Biomedicine and Engineering Article
PDF (1.2 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Splenic Transcriptome Profiling of the Patients with Post-Hepatitis B Liver Cirrhosis and Portal Hypertension

Lingxiang Yu#, Xiaodong Guo#, Zhiwei Li, Shaogeng Zhang( )
Department of Hepatobiliary Surgery, 302 Hospital of PLA, Beijing 100039, PR China

#These authors contributed equally to this paper and should be regarded as co-first author

Show Author Information

Abstract

The infection with hepatitis B virus is the common cause of liver cirrhosis, and portal hypertensionis is one of the main causes of morbidity and mortality in patients with cirrhosis, which has attracted extensive attention for its fatal complications worldwide. By comparing the expression pattern to normal spleen tissues through RNA-Seq technology, we identified a list of protein-coding genes that were expressed differentially between patient and normal samples. Especially the secretory cytokines, including chemokine activity-related genes and immediate early response genes, were significantly upregulated in spleen samples. The results and genes identified in this study revealed the similar expression pattern in human samples to that reported in murine model, which further support the thesis that the spleen could take a harmful role and provide a negative impact in this situation due to inducing chemokine and transcription factor.

Keywords

Hepatitis BLiver cirrhosisPortal hypertensionTranscriptome sequencing

References

[1]

E. Thomas, M.Yoneda and E.R. Schiff, Viral hepatitis: Past and future of hbv and hdv. Cold Spring Harbor Perspectives in Medicine, 2015, 5(2): 5.
Crossref Google Scholar
[2]

H.C. Yang, J.H. Kao, Viral hepatitis: Hbv cure-can we pin our hopes on immunotherapy? Nature Reviews. Gastroenterology & Hepatology, 2015, 12: 129-131.
Crossref Google Scholar
[3]

C. Ferrari, HBV and the immune response. Liver International, 2015, 35(1): 121-128.
Crossref Google Scholar
[4]

C. Trepo, H.L. Chan and A. Lok, Hepatitis b virus infection. Lancet, 2014, 384: 2053-2063.
Crossref Google Scholar
[5]

M.R. Kappus, R.K. Sterling, Extrahepatic manifestations of acute hepatitis b virus infection. Gastroenterology & Hepatology, 2013, 9: 123-126.
Google Scholar
[6]

E.A. Tsochatzis, J. Bosch and A.K. Burroughs, Liver cirrhosis. Lancet, 2014, 383: 1749-1761.
Crossref Google Scholar
[7]
G. D'Amico, Natural history and stages of cirrhosis. In R. de Franchis, A. Dell’Era (Eds.), Variceal Hemorrhage. Springer New York, 2014: 15-28.
Crossref
[8]

M.Y. Kim, S.K. Baik and S.S. Lee, Hemodynamic alterations in cirrhosis and portal hypertension. The Korean Journal of Hepatology, 2010, 16: 347-352.
Crossref Google Scholar
[9]

S.K. Baik, T.R. Fouad and S.S. Lee, Cirrhotic cardiomyopathy. Orphanet Journal of Rare Diseases, 2007, 2: 15.
Crossref Google Scholar
[10]

P.A. McGettigan, Transcriptomics in the rna-seq era. Current Opinion in Chemical Biology, 2013, 17: 4-11.
Crossref Google Scholar
[11]

J.A. Martin, Z. Wang, Next-generation transcriptome assembly. Nature Reviews Genetics, 2011, 12: 671-682.
Crossref Google Scholar
[12]

Z. Wang, M. Gerstein and M. Snyder, Rna-seq: A revolutionary tool for transcriptomics. Nature Reviews Genetics, 2009, 10: 57-63.
Crossref Google Scholar
[13]

H.L. Ho, H.C. Huang, Molecular mechanisms of circulatory dysfunction in cirrhotic portal hypertension. Journal of the Chinese Medical Association, 2015, 78(4): 195-203.
Crossref Google Scholar
[14]

J.C. Garcia-Pagan, J. Gracia-Sancho and J. Bosch, Functional aspects on the pathophysiology of portal hypertension in cirrhosis. Journal of Hepatology, 2012, 57: 458-461.
Crossref Google Scholar
[15]

M. Pinzani, M. Rosselli and M. Zuckermann, Liver cirrhosis. Best Practice & Research. Clinical Gastroenterology, 2011, 25: 281-290.
Crossref Google Scholar
[16]

B. Smedsrod, D. Le Couteur, K. Ikejima, et al., Hepatic sinusoidal cells in health and disease: Update from the 14th international symposium. Liver International, 2009, 29: 490-501.
Crossref Google Scholar
[17]

L.D. DeLeve, Hepatic microvasculature in liver injury. Seminars in Liver Disease, 2007, 27: 390-400.
Crossref Google Scholar
[18]

J. Bosch, J.G. Abraldes, M. Fernandez, et al., Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension. Journal of Hepatology, 2010, 53: 558-567.
Crossref Google Scholar
[19]

R.E. Mebius, G.Kraal, Structure and function of the spleen. Nature reviews. Immunology, 2005, 5, 606-616.
Crossref Google Scholar
[20]

Y. Arakawa, M. Shimada, T. Utsunomiya, et al., Gene profile in the spleen under massive partial hepatectomy using complementary DNA microarray and pathway analysis. Journal of Gastroenterology and Hepatology, 2014, 29: 1645-1653.
Crossref Google Scholar
[21]

X.P. Chen, Z.D. Wu, Z.Y. Huang, et al., Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. The British Journal of Surgery, 2005, 92: 334-339.
Crossref Google Scholar
[22]

M. Shimada, H. Ijichi, Y. Yonemura, et al., The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepato-Gastroenterology, 2004, 51: 625-629.
Google Scholar
[23]

Y. Sugawara, J. Yamamoto, K. Shimada, et al., Splenectomy in patients with hepatocellular carcinoma and hypersplenism. Journal of the American College of Surgeons, 2000, 190: 446-450.
Crossref Google Scholar
[24]

S.F. Yan, T. Fujita, J. Lu, et al., Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nature Medicine, 2000, 6: 1355-1361.
Crossref Google Scholar
Nano Biomedicine and Engineering
Volume 8 Issue 3,
September 2016
Pages 184-189
DOI: 10.5101/nbe.v8i3.p184-189
Cite this article:
Yu L, Guo X, Li Z, et al. Splenic Transcriptome Profiling of the Patients with Post-Hepatitis B Liver Cirrhosis and Portal Hypertension. Nano Biomedicine and Engineering, 2016, 8(3): 184-189. https://doi.org/10.5101/nbe.v8i3.p184-189

391

Views

11

Downloads

1

Crossref

2

Scopus

Altmetrics
Received: 19 September 2016
Accepted: 20 September 2016
Published: 28 September 2016
© 2016 Lingxiang Yu, Xiaodong Guo, Zhiwei Li and Shaogeng Zhang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Return